Senior insider sale
CLIMB BIO, INC. — senior position signals high conviction
$556.0K
100K shares
What this filing means
THOMAS STEPHEN BASIL plans to sell 100K shares of CLIMB BIO, INC. valued at approximately $556.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/12/2026ACC: 0001950047-26-001212
100K
Shares to sell
$556.0K
Approx. market value
100K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Units
N/A
1/1/2025
50.19KFounders Shares
N/A
11/15/2023
49.81KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/1/2025 | Restricted Stock Units N/A | 50.19K | — |
11/15/2023 | Founders Shares N/A | 49.81K | — |
| Total | 100K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
100K
Market value
$556.0K
2/12/2026
Total
Units
100K
Value
$556.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/12/2026 | 100K | $556.0K | NASDAQ | Planned |
| Total | 100K | $556.0K | ||